Litcius/Paper detail

Efficacy and safety of a novel low-dose triple single-pill combination of telmisartan, amlodipine and indapamide, compared with dual combinations for treatment of hypertension: a randomised, double-blind, active-controlled, international clinical trial

Anthony Rodgers, Abdul Salam, Aletta E. Schutte, William C. Cushman, H Asita de Silva, Gian Luca Di Tanna, Diederick E. Grobbee, Krzysztof Narkiewicz, Dike Ojji, Neil R Poulter, Markus P. Schlaich, Suzanne Oparil, Wilko Spiering, Bryan Williams, Jackson T. Wright, Poopalan Lakshman, W. Uluwattage, Peter Hay, Tiago Pereira, Najith Amarasena, Gotabhaya Ranasinghe, Christopher Gianacas, Mathangi Shanthakumar, Xiaoqiu Liu, Nelson Wang, Sonali R. Gnanenthiran, Paul K. Whelton

2024The Lancet37 citationsDOI

Topics & Concepts

MedicineAmlodipineIndapamideDouble blindTelmisartanPillPharmacologyRandomized controlled trialInternal medicineUrologyBlood pressureAlternative medicineDiureticPlaceboPathologyBlood Pressure and Hypertension StudiesRenin-Angiotensin System StudiesPharmaceutical Economics and Policy